FDA approves new label language for Afrezza


Michael Castagna, new CEO of MannKind Corporation, stands in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. Michael Castagna, new CEO of MannKind Corporation, stands in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017.



from Biotech News